Member access

4-Traders Homepage  >  Shares  >  Xetra  >  Merck KGaA    MRK   DE0006599905


SummaryQuotesChart AnalysisNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll news 

Merck KGaA May Withdraw Research from Portugal over Debt-Report

07/09/2012 | 02:28am US/Eastern

German chemical company Merck KGaA (>> Merck KGaA) may withdraw future investments for research projects in Portugal worth tens of millions of euros unless the government hospitals stick to the agreed-upon debt repayments, German daily newspaper Financial Times Deutschland reports Monday.

Merck Portugal's manager Fritz Sacher told the paper the company's research projects are long-term and require mutual trust as a basis. "The Portuguese government's lacking payment habits undermine this trust," he is quoted as saying.

Portuguese government hospitals owe the pharmaceutical industry a total of more than 1.5 billion euros ($1.84 billion) and companies have to wait nearly 550 days on average until invoices are paid, FTD reports.

Some companies, including Roche Holding AG (ROG.VX), have already halted the sale of medications on credit to highly indebted countries like Portugal, Greece, Spain and Italy until outstanding debts are paid, the paper notes, but for many companies such drastic steps are difficult as they carry responsibility for people's wellbeing.

Withdrawing research projects is a way of putting pressure on the government, as Portugal is an attractive location for research investments, FTD says. "The conditions for certain research and human studies are as good as in the U.S., but it's significantly more cost-effective in Portugal," Sacher told the paper.

Newspaper website:

Write to the Frankfurt Bureau at

Stocks mentioned in the article : Merck KGaA
React to this article
Latest news on MERCK KGAA
1d ago MERCK KGAA : Darmstadt, Germany, Announces Global Strategic Alliance with Pfizer..
1d ago MERCK KGAA : Pfizer Forms Global Strategic Alliance with Merck KGaA, Germany, to..
2d ago MERCK KGAA : Darmstadt, Germany, Commissions Biomass Energy Plant in India
2d ago MERCK KGAA : Commissions Biomass Energy Plant in India
2d ago MERCK KGAA : EMD Millipore Assigned Patent
6d ago MERCK KGAA : Maintenance Agreement Renewal Sought by Health and Human Services
11/18 Pfizer, Merck strike $2.85B deal as hope of AstraZeneca merger wanes
11/18DJLONDON MARKETS : AstraZeneca Advances In London; Pound Rises As Inflation Ticks ..
11/18 MERCK KGAA : EMD Millipore Assigned Patent
11/18 AstraZeneca trumpets solo strength in cancer drugs post Pfizer struggle
Duration : Period :
Merck KGaA Technical Analysis Chart | MRK | DE0006599905 | 4-Traders
Income Statement Evolution
More Financials
Dynamic quotes